London, United Kingdom

Florent Mouliere

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Cancer Research Technology Limited. Active years: 2025-2026.


% Patents Active = 50.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Florent Mouliere: Innovator in DNA Detection Technology

Introduction

Florent Mouliere is a notable inventor based in London, GB. He has made significant contributions to the field of molecular biology, particularly in the detection of variant nucleic acids. His innovative approach has the potential to enhance diagnostic capabilities in various medical applications.

Latest Patents

Mouliere holds a patent for an invention titled "Enhanced detection of target DNA by fragment size analysis." This computer-implemented method provides a way to detect variant nucleic acid from a cell-free nucleic acid-containing sample. The method involves analyzing fragment sizes of nucleic acid fragments and processing this data through a classification algorithm. This algorithm classifies the sample data into categories that indicate the presence or absence of variant nucleic acid, thereby determining the likelihood of its presence.

Career Highlights

Florent Mouliere is associated with Cancer Research Technology Limited, where he applies his expertise in developing advanced detection methods. His work is crucial in the ongoing efforts to improve cancer diagnostics and treatment strategies. With 1 patent to his name, he continues to push the boundaries of innovation in his field.

Collaborations

Mouliere collaborates with talented professionals such as Dineika Chandrananda and Anna Piskorz. Their combined efforts contribute to the advancement of research and technology in cancer detection.

Conclusion

Florent Mouliere's contributions to DNA detection technology exemplify the impact of innovative thinking in the medical field. His work not only enhances our understanding of genetic variations but also paves the way for improved diagnostic methods.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…